Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002249454 | SCV002516765 | benign | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
University of Washington Center for Mendelian Genomics, |
RCV000755136 | SCV000882958 | likely pathogenic | Childhood apraxia of speech | 2016-04-27 | no assertion criteria provided | research | |
Gene Friend Way, |
RCV003313976 | SCV004013889 | likely pathogenic | Autism spectrum disorder | 2023-07-28 | no assertion criteria provided | clinical testing | Missense mutation. The ZGRF1 gene product localizes to the cell nucleus and promotes DNA repair by stimulating homologous recombination. ZGRF1 variants have been associated with speech and language disorders (PMID: 21663442). This variant has been found in patients with childhood apraxia of speech (PMID: 27120335). In our study, seven children diagnosed with autism spectrum disorder carry both ZGRF1 rs61745597 and ZGRF1 rs76187047. |